Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gala Therapeutics

Gala Therapeutics
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$27.5M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of disease modifying therapies intended to improve survival, quality of life and outcomes for patients with lung cancer, COPD, asthma and other pulmonary diseases. The company's therapies address the needs of interventional pulmonologists, thoracic surgeons and all physicians who treat pulmonary disease, enabling physicians to treat their patients better, resulting in a better medical outcome.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 155 Jefferson Street
  • Suite 100
  • Menlo Park, CA 94025
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gala Therapeutics’s full profile, request a free trial.

Gala Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 11-Mar-2019 $27.5M 000.00 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Gala Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Gala Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nuvaira Venture Capital-Backed Minneapolis, MN 00 00000 0000000000 0 00000
000 0000000 Venture Capital-Backed Lexington, MA 00 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

Gala Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Apple Tree Partners Venture Capital Minority 000 0000 000000 0

Gala Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Jonathan Waldstreicher MD Founder, Chief Executive Officer, President & Board Member
Deborah Sheffield Vice President of Regulatory & Quality Affairs
Kevin Taylor Vice President, Research & Development

Gala Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
David McIntyre Apple Tree Partners Board Member 000 0000
Jonathan Waldstreicher MD Gala Therapeutics Founder, Chief Executive Officer, President & Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »